肾盂癌的诊疗现状与进展
倪志福， 王健 - 现代泌尿生殖肿瘤杂志, 2015 - cqvip.com
肾盂癌约占尿路上皮肿瘤的4%-6%, 病理类型以尿路上皮细胞癌最为常见, 约占90%;
鳞状细胞癌小于10%, 且多与长期结石, 感染等刺激因素有关; 腺癌罕见[1-2] …
鳞状细胞癌小于10%, 且多与长期结石, 感染等刺激因素有关; 腺癌罕见[1-2] …
Upper tract urothelial carcinoma
KD Linton, JWF Catto - Journal of Clinical Urology, 2013 - journals.sagepub.com
Upper tract urothelial carcinoma (UTUC) accounts for approximately 5% of all urothelial
carcinoma. There are many risk factors for UTUC, including environmental and genetic risk …
carcinoma. There are many risk factors for UTUC, including environmental and genetic risk …
[HTML][HTML] Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
YH Ko - Translational Cancer Research, 2020 - ncbi.nlm.nih.gov
Given the more aggressive phenotype and prognosis of the upper tract urothelial carcinoma
(UTUC) than those of bladder tumor, radical removal of the entire ureter along with …
(UTUC) than those of bladder tumor, radical removal of the entire ureter along with …
Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates …
Introduction The treatment standard for high-risk upper urinary tract urothelial carcinoma
(UUTUC) is radical nephroureterectomy. However, some patients may be unfit or unwilling …
(UUTUC) is radical nephroureterectomy. However, some patients may be unfit or unwilling …
Trattamento conservativo dei tumori della via escretrice superiore
L Lenfant, T Seisen, J Parra, C Vaessen… - EMC-Tecniche …, 2022 - Elsevier
I tumori uroteliali della via escretrice superiore (TVES) sono rari e il loro trattamento dipende
dal rischio oncologico, dalla localizzazione tumorale (caliceale o ureterale) e dal contesto …
dal rischio oncologico, dalla localizzazione tumorale (caliceale o ureterale) e dal contesto …
Formidable scenarios in urothelial and variant cancers of the urinary tract
JB Aragon-Ching, A Choudhury, V Margulis… - American Society of …, 2019 - ascopubs.org
Diagnostic and therapeutic challenges in the field of bladder and upper tract cancers
provide opportunities for multidisciplinary care. Urothelial cancers make up the majority of …
provide opportunities for multidisciplinary care. Urothelial cancers make up the majority of …
Urothelkarzinom des oberen Harntraktes: aktuelle Behandlungsstrategien
M Marx, LM Krabbe, F Wezel, JT Klein, F Zengerling… - Die Onkologie, 2022 - Springer
Zusammenfassung Hintergrund Das Therapiespektrum des Urothelkarzinoms des oberen
Harntraktes ist breit und hängt maßgeblich von der individuellen Risikokonstellation ab …
Harntraktes ist breit und hängt maßgeblich von der individuellen Risikokonstellation ab …
Tumor de la vía excretora superior
Los tumores de la vía excretora superior (TVES) son infrecuentes y representan el 5-10% de
los carcinomas uroteliales. La incidencia anual estimada en los países occidentales es de …
los carcinomas uroteliales. La incidencia anual estimada en los países occidentales es de …
Percutaneous instillation of chemolytic, chemotherapeutic, and antifungal agents
MA Elkoushy, PD Violette… - Smith's Textbook of …, 2012 - Wiley Online Library
Percutaneous therapy delivers medications directly into the collecting system, allowing high
local concentrations while avoiding potential systemic complications. In this chapter …
local concentrations while avoiding potential systemic complications. In this chapter …